9 results on '"Van Poppel, Hendrick"'
Number of results to display per page
Search Results
2. Epidemiology and Prevention of Prostate Cancer
- Author
-
Gandaglia, Giorgio, primary, Leni, Riccardo, additional, Bray, Freddie, additional, Fleshner, Neil, additional, Freedland, Stephen J., additional, Kibel, Adam, additional, Stattin, Pär, additional, Van Poppel, Hendrick, additional, and La Vecchia, Carlo, additional
- Published
- 2021
- Full Text
- View/download PDF
3. PD34-02 THE KEY ROLE OF PSA DOUBLING TIME IN PATIENTS TREATED WITH SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR THE EXTENT OF RADIATION AND THE CONCOMITANT USE OF HORMONAL THERAPY
- Author
-
Fossati, Nicola, primary, Karnes, R Jeffrey, additional, Boorjian, Stephen A, additional, Motterle, Giovanni, additional, Bossi, Alberto, additional, Kumar, Tami, additional, Di Muzio, Nadia, additional, Cesare, Cozzarini, additional, Chiorda, Barbara Noris, additional, Mazzone, Elio, additional, Robesti, Daniele, additional, Gandaglia, Giorgio, additional, Bartkowiak, Detlef, additional, Shariat, Shahrokh, additional, Goldner, Gregor, additional, Joniau, Steven, additional, Van Poppel, Hendrick, additional, Berghen, Charlien, additional, De Meerleer, Gert, additional, Montorsi, Francesco, additional, Wiegel, Thomas, additional, and Briganti, Alberto, additional
- Published
- 2021
- Full Text
- View/download PDF
4. IMAGINE-IMpact Assessment of Guidelines Implementation and Education : The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines
- Author
-
Cornford, Philip, Smith, Emma Jane, MacLennan, Steven, Pereira-Azevedo, Nuno, Roobol, Monique J., Lumen, Nicolaas, Fullwood, Louise, Duncan, Eilidh, Dunsmore, Jennifer, Plass, Karin, Ribal, Maria J., Knoll, Thomas, Bjartell, Anders, Van Poppel, Hendrick, N'Dow, James, Briganti, Alberto, Cornford, Philip, Smith, Emma Jane, MacLennan, Steven, Pereira-Azevedo, Nuno, Roobol, Monique J., Lumen, Nicolaas, Fullwood, Louise, Duncan, Eilidh, Dunsmore, Jennifer, Plass, Karin, Ribal, Maria J., Knoll, Thomas, Bjartell, Anders, Van Poppel, Hendrick, N'Dow, James, and Briganti, Alberto
- Abstract
Adherence to national and international clinical practice guidelines is suboptimal throughout Europe. The European Association of Urology Guidelines Office project "IMAGINE" (IMpact Assessment of Guidelines Implementation and Education) has been developed to measure baseline adherence to urological guideline recommendations across Europe and to identify issues that drive nonadherence.
- Published
- 2021
- Full Text
- View/download PDF
5. Epidemiology and Prevention of Prostate Cancer
- Author
-
Gandaglia, Giorgio, Leni, Riccardo, Bray, Freddie, Fleshner, Neil, Freedland, Stephen J, Kibel, Adam, Stattin, Pär, Van Poppel, Hendrick, La Vecchia, Carlo, Gandaglia, Giorgio, Leni, Riccardo, Bray, Freddie, Fleshner, Neil, Freedland, Stephen J, Kibel, Adam, Stattin, Pär, Van Poppel, Hendrick, and La Vecchia, Carlo
- Abstract
CONTEXT: Worldwide, prostate cancer (PCa) represents the second most common solid tumor in men. OBJECTIVE: To assess the geographical distribution of PCa, epidemiological differences, and the most relevant risk factors for the disease. EVIDENCE ACQUISITION: Estimated incidence, mortality, and prevalence of PCa for the year 2020 in 185 countries were derived from the IARC GLOBOCAN database. A review of English-language articles published between 2010 and 2020 was conducted using MEDLINE, EMBASE, and Scopus to identify risk factors for PCa. EVIDENCE SYNTHESIS: In the year 2020, there were over 1414000 estimated new cases of PCa worldwide, with an age-standardized rate (ASR) incidence of 31 per 100000 (lifetime cumulative risk: 3.9%). Northern Europe has the highest all-age incidence ASR (83), while the lowest ASR was in South-Central Asia (6.3). In the year 2020, there were over 375000 estimated deaths worldwide, and the overall mortality ASR was 7.7 per 100000, with the highest ASR in the Caribbean (28) and the lowest in South-Central Asia (3.1). Family history, hereditary syndromes, and race are the strongest risk factors for PCa. Metabolic syndrome was associated with the risk of developing PCa, high-grade disease, and adverse pathology. Diabetes and exposure to ultraviolet rays were found to be inversely associated to PCa incidence. Cigarette smoking and obesity may increase PCa-specific mortality, while regular physical activity may reduce disease progression. Although 5-alpha reductase inhibitors are known to be associated with a reduced incidence of PCa, available studies failed to show an effect on overall mortality. CONCLUSIONS: Family history, race, and hereditary syndromes are well-established risk factors for PCa. Modifiable risk factors may impact the risk of developing PCa and that of dying from the disease, but little evidence exist for any clear indication for prevention other than early diagnosis to reduce PCa mortality. PATIENT SUMMARY: Prostate canc
- Published
- 2021
- Full Text
- View/download PDF
6. IMAGINE—IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines
- Author
-
Cornford, Philip, primary, Smith, Emma Jane, additional, MacLennan, Steven, additional, Pereira-Azevedo, Nuno, additional, Roobol, Monique J., additional, Lumen, Nicolaas, additional, Fullwood, Louise, additional, Duncan, Eilidh, additional, Dunsmore, Jennifer, additional, Plass, Karin, additional, Ribal, Maria J., additional, Knoll, Thomas, additional, Bjartell, Anders, additional, Van Poppel, Hendrick, additional, N’Dow, James, additional, Briganti, Alberto, additional, Dorfinger, Karl, additional, Resch, Irene, additional, Johannes, Mischinger, additional, Heidegger, Isabel, additional, Assenmacher, Christophe, additional, Roumeguère, Thierry, additional, Decaestecker, Karel, additional, Goeman, Lieven, additional, Adams, Thomas, additional, Georgiev, Marincho, additional, Yanev, Krassimir, additional, Timev, Aleksandar, additional, Tomašković, Igor, additional, Kuliš, Tomislav, additional, Charalampous, Stavros, additional, Kontaxis, Dimitris, additional, Babjuk, Marko, additional, Zachoval, Roman, additional, Pitra, Tomáš, additional, Novák, Vojtěch, additional, Lund, Lars, additional, Kivi, Martin, additional, Baum, Peep, additional, Tamm, Toomas, additional, Veskimae, Pritt, additional, Okas, Rauno, additional, Lahdensuo, Kanerva, additional, Taari, Kimmo, additional, Seikkula, Heikki, additional, Jämsä, Pyry, additional, Gamé, Xavier, additional, Fournier, George, additional, Ingels, Alexandre, additional, Fiard, Gaelle, additional, Ploussard, Guillaume, additional, Rassweiler, Jens, additional, Schmidt, Stefanie, additional, Kranz, Jennifer, additional, Krege, Susanne, additional, Gkialas, Ioannis, additional, Dellis, Anthanasios, additional, Ferakis, Nikolaos, additional, Mitropoulos, Dionysios, additional, Ryan, Peter, additional, Sweeney, John Paul, additional, Rogers, Eamonn, additional, Hennessy, Derek, additional, Davis, Niall. F., additional, Artibani, Walter, additional, Porpiglia, Francesco, additional, Giuseppe Voce, Salvatore, additional, Brausi, Maurizio, additional, Cerruto, Maria A., additional, Esperto, Francesco, additional, Manfredi, Matteo, additional, Jievaltas, Mindaugas, additional, Patašius, Aušvydas, additional, Čekauskas, Albertas, additional, Auškalnis, Stasys, additional, Mulders, Peter, additional, Martens, Frank, additional, D'Hauwers, Kathleen W.M., additional, Chlosta, Piotr, additional, Katarzyna Czech, Anna, additional, Gronostaj, Katarzyna, additional, Przydacz, Mikołaj, additional, Coelho Nunes, Pedro, additional, Abranches-Monteiro, Luís, additional, Pereira e Silva, Ricardo, additional, Furriel, Frederica, additional, Gomes Monteiro, Pedro, additional, Sinescu, Ioanel, additional, Surcel, Cristian, additional, Baston, Catalin, additional, Ionut Stoica, Robert, additional, Olaru, Vlad, additional, Kollárik, Boris, additional, Mincik, Ivan, additional, Rybár, Ľuboš, additional, Kováčik, Viktor, additional, Perečinský, Ivan, additional, Kosuta, Boris, additional, Zupancic, Marko, additional, Taskovska, Milena, additional, Kacjan, Uros, additional, Miklavzina, Andraz, additional, Esteban Fuertes, Manuel, additional, Alvarez-Maestro, Mario, additional, Vilaseca, Antoni, additional, García-Baquero, Rodrigo, additional, Renström Koskela, Lotta, additional, Styrke, Johan, additional, Galiqi, Gezim, additional, Hoxha, Bilbil, additional, Zhapa, Evisa, additional, Xhani, Rezart, additional, Fanarjyan, Sergey, additional, Hovhannisyan, Ruben, additional, Armen, Avoyan E., additional, Badalyan, Rafael, additional, Hiroš, Mustafa, additional, Tomić, Davor, additional, Aganović, Damir, additional, Chkhotua, Archil, additional, Nikoleishvili, David, additional, Tchanturaia, Zara, additional, Gudjónsson, Sigurdur, additional, Orri Gudmundsson, Eirikur, additional, Hilmarsson, Rafn, additional, Ceban, Emil, additional, Ghicavii, Vitalii, additional, Tanase, Adrian, additional, Vasiliev, Vladislav, additional, Perovic, Dragoljub, additional, Vukovic, Marko, additional, Rade, Stanisavljevic, additional, Radovic, Nenad, additional, Nasufovic, Emil, additional, Alyaev, Yuri, additional, Korneyev, Igor, additional, Kotov, Sergei, additional, Malkhasyan, Vigen, additional, Basic, Dragoslav, additional, Aćimović, Miodrag, additional, Vojinov, Saša, additional, Vuksanovic, Aleksandar, additional, Bumbaširević, Uroš, additional, Čegar, Bojan, additional, Stanković, Branko, additional, Danuser, Hansjörg, additional, Sulser, Tullio, additional, Zumstein, Valentin, additional, Kadioglu, Ates, additional, Kilicarslan, Hakan, additional, Can Cilesiz, Nusret, additional, Demirelli, Erhan, additional, Önal, Bülent, additional, Mungan, Aydin, additional, Tekgül, Serdar, additional, Türkeri, Levent, additional, Esen, Adil, additional, Shulyak, Oleksandr, additional, Vozianov, Sergiy, additional, Shulyak, Alexandr, additional, Volkov, Serhii, additional, and Nesterchuk, Andrii, additional
- Published
- 2021
- Full Text
- View/download PDF
7. IMAGINE—IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines
- Author
-
Dorfinger, Karl, Resch, Irene, Johannes, Mischinger, Heidegger, Isabel, Assenmacher, Christophe, Roumeguère, Thierry, Decaestecker, Karel, Goeman, Lieven, Adams, Thomas, Georgiev, Marincho, Yanev, Krassimir, Timev, Aleksandar, Tomašković, Igor, Kuliš, Tomislav, Charalampous, Stavros, Kontaxis, Dimitris, Babjuk, Marko, Zachoval, Roman, Pitra, Tomáš, Novák, Vojtěch, Lund, Lars, Kivi, Martin, Baum, Peep, Tamm, Toomas, Veskimae, Pritt, Okas, Rauno, Lahdensuo, Kanerva, Taari, Kimmo, Seikkula, Heikki, Jämsä, Pyry, Gamé, Xavier, Fournier, George, Ingels, Alexandre, Fiard, Gaelle, Ploussard, Guillaume, Rassweiler, Jens, Schmidt, Stefanie, Kranz, Jennifer, Krege, Susanne, Gkialas, Ioannis, Dellis, Anthanasios, Ferakis, Nikolaos, Mitropoulos, Dionysios, Ryan, Peter, Sweeney, John Paul, Rogers, Eamonn, Hennessy, Derek, Davis, Niall. F., Artibani, Walter, Porpiglia, Francesco, Giuseppe Voce, Salvatore, Brausi, Maurizio, Cerruto, Maria A., Esperto, Francesco, Manfredi, Matteo, Jievaltas, Mindaugas, Patašius, Aušvydas, Čekauskas, Albertas, Auškalnis, Stasys, Mulders, Peter, Martens, Frank, D'Hauwers, Kathleen W.M., Chlosta, Piotr, Katarzyna Czech, Anna, Gronostaj, Katarzyna, Przydacz, Mikołaj, Coelho Nunes, Pedro, Abranches-Monteiro, Luís, Pereira e Silva, Ricardo, Furriel, Frederica, Gomes Monteiro, Pedro, Sinescu, Ioanel, Surcel, Cristian, Baston, Catalin, Ionut Stoica, Robert, Olaru, Vlad, Kollárik, Boris, Mincik, Ivan, Rybár, Ľuboš, Kováčik, Viktor, Perečinský, Ivan, Kosuta, Boris, Zupancic, Marko, Taskovska, Milena, Kacjan, Uros, Miklavzina, Andraz, Esteban Fuertes, Manuel, Alvarez-Maestro, Mario, Vilaseca, Antoni, García-Baquero, Rodrigo, Renström Koskela, Lotta, Styrke, Johan, Galiqi, Gezim, Hoxha, Bilbil, Zhapa, Evisa, Xhani, Rezart, Fanarjyan, Sergey, Hovhannisyan, Ruben, Armen, Avoyan E., Badalyan, Rafael, Hiroš, Mustafa, Tomić, Davor, Aganović, Damir, Chkhotua, Archil, Nikoleishvili, David, Tchanturaia, Zara, Gudjónsson, Sigurdur, Orri Gudmundsson, Eirikur, Hilmarsson, Rafn, Ceban, Emil, Ghicavii, Vitalii, Tanase, Adrian, Vasiliev, Vladislav, Perovic, Dragoljub, Vukovic, Marko, Rade, Stanisavljevic, Radovic, Nenad, Nasufovic, Emil, Alyaev, Yuri, Korneyev, Igor, Kotov, Sergei, Malkhasyan, Vigen, Basic, Dragoslav, Aćimović, Miodrag, Vojinov, Saša, Vuksanovic, Aleksandar, Bumbaširević, Uroš, Čegar, Bojan, Stanković, Branko, Danuser, Hansjörg, Sulser, Tullio, Zumstein, Valentin, Kadioglu, Ates, Kilicarslan, Hakan, Can Cilesiz, Nusret, Demirelli, Erhan, Önal, Bülent, Mungan, Aydin, Tekgül, Serdar, Türkeri, Levent, Esen, Adil, Shulyak, Oleksandr, Vozianov, Sergiy, Shulyak, Alexandr, Volkov, Serhii, Nesterchuk, Andrii, Cornford, Philip, Smith, Emma Jane, MacLennan, Steven, Pereira-Azevedo, Nuno, Roobol, Monique J., Lumen, Nicolaas, Fullwood, Louise, Duncan, Eilidh, Dunsmore, Jennifer, Plass, Karin, Ribal, Maria J., Knoll, Thomas, Bjartell, Anders, Van Poppel, Hendrick, N’Dow, James, and Briganti, Alberto
- Published
- 2021
- Full Text
- View/download PDF
8. Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models
- Author
-
Pecoraro, Alessio, Campi, Riccardo, Bertolo, Riccardo, Carmen Mir, Maria, Marchioni, Michele, Serni, Sergio, Joniau, Steven, Van Poppel, Hendrick, Albersen, Maarten, and Roussel, Eduard
- Abstract
We summarize the latest evidence on models for predicting mid- to long-term postoperative renal function after surgery for localized renal masses. None of the models available is ready for integration in the clinic and further studies are needed to explore their utility in clinical decision-making.
- Published
- 2023
- Full Text
- View/download PDF
9. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series
- Author
-
Hendrick Van Poppel, Alberto Bossi, Nicola Fossati, Stephen A. Boorjian, Barbara Noris Chiorda, Piet Ost, Alberto Briganti, Gert De Meerleer, Francesco Montorsi, Karin Haustermans, Giorgio Gandaglia, R. Jeffrey Karnes, A. Battaglia, Cesare Cozzarini, Valérie Fonteyne, Thomas Wiegel, Thomas Seisen, Emanuele Zaffuto, Steven Joniau, Shahrokh F. Shariat, Gregor Goldner, Nadia Di Muzio, Michele Colicchia, Gandaglia, Giorgio, Fossati, Nicola, Karnes, R Jeffrey, Boorjian, Stephen A, Colicchia, Michele, Bossi, Alberto, Seisen, Thoma, Cozzarini, Cesare, Di Muzio, Nadia, Noris Chiorda, Barbara, Zaffuto, Emanuele, Wiegel, Thoma, Shariat, Shahrokh F, Goldner, Gregor, Joniau, Steven, Battaglia, Antonino, Haustermans, Karin, De Meerleer, Gert, Fonteyne, Valérie, Ost, Piet, Van Poppel, Hendrick, Montorsi, Francesco, and Briganti, Alberto
- Subjects
Biochemical recurrence ,Oncology ,Male ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,Long Term Adverse Effects ,Kaplan-Meier Estimate ,Androgen deprivation therapy ,Metastasis ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Internal medicine ,Outcome Assessment, Health Care ,Medicine ,Humans ,Neoplasm Metastasis ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Prostatectomy ,Salvage Therapy ,Radiotherapy ,business.industry ,Patient Selection ,Hazard ratio ,Prostate ,Prostatic Neoplasms ,Androgen Antagonists ,Middle Aged ,Prostate-Specific Antigen ,medicine.disease ,Radical prostatectomy ,Radiation therapy ,Salvage radiotherapy ,Europe ,030220 oncology & carcinogenesis ,Concomitant ,Neoplasm Recurrence, Local ,business - Abstract
Background Hormonal manipulation concomitant to salvage radiotherapy (SRT) given for biochemical recurrence (BCR) after radical prostatectomy (RP) improved outcomes in two randomized trials. However, neither of these studies focused on men treated at low prostate-specific antigen (PSA) levels. Objective To test if the impact of androgen deprivation therapy (ADT) on metastasis in patients undergoing early SRT varies according to prostate cancer (PCa) features. Design, setting, and participants A total of 525 patients received SRT at PSA levels ≤2ng/ml. Outcome measurements and statistical analyses Multivariable Cox regression analyses assessed factors associated with metastasis. We tested the hypothesis that the impact of ADT varied according to the risk of metastasis. An interaction with groups (concomitant ADT vs no ADT) and the probability of distant metastasis according to a newly developed model was tested. A nonparametric curve explored the relationship between the risk of metastasis and 10-yr metastasis rates according to ADT. Results and limitations Median PSA and radiotherapy dose were 0.42ng/ml and 66Gy, respectively. Overall, 178 (34%) patients received ADT. At a median follow-up of 104 mo, 71 patients experienced metastasis. Grade group ≥4 (hazard ratio [HR]: 1.66; 95% confidence interval [CI]: 1.01–3.30), pT3b/4 (HR: 2.61; 95% CI: 1.51–4.52), and dose (HR: 0.82; 95% CI: 0.76–0.89) were associated with metastasis. The impact of ADT differed according to the risk of metastasis calculated using a multivariable model (p=0.01). This was confirmed when considering patients treated with early SRT (p=0.046), where ADT was associated with a reduction in the rate of metastasis only in eSRT; patients with more aggressive characteristics (ie, pT3b/4 and grade group ≥4, or pT3b/4 and PSA at eSRT ≥0.4ng/ml). Conclusions The beneficial effect of ADT concomitant to eSRT varied significantly according to disease characteristics, such that only men with more aggressive PCa features benefit from ADT in the eSRT setting for BCR after RP. Patient summary The oncological benefits of concomitant androgen deprivation therapy (ADT) in patients undergoing salvage radiotherapy (SRT) vary according to pathological characteristics. Only patients with more aggressive disease characteristics seemed to benefit from the use of hormonal manipulation at the time of early SRT. Conversely, the potential side effects of ADT could be spared in patients with low prostate-specific antigen levels and favorable pathological features.
- Published
- 2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.